// App-Quantinova.ai

2032.0 : Impact of an immuno-oncology (IO) education/monitoring program on patient’s self-efficacy and adverse event reporting from immune checkpoint inhibitors (ICIs).

Researchers

Presenter

  • Parneet Kaur Cheema

Principal Investigators

  • Massey Nematollahi

  • FeRevelyn Berco

  • Janet Papadakos

  • Deepanjali Kaushik

  • Priscilla Matthews

  • Marco Iafolla

  • Kirstin Perdrizet

  • Margaret Balcewicz

  • William Raskin

  • Stephen Reingold

  • Juhi Husain

  • Philip Kuruvilla

  • Henry Jacob Conter

Medical Centers

  • William Osler Health System, University of Toronto, Toronto, Ontario, Canada.

  • William Osler Health System, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved